−77.58 M USD
0.00 USD
16.48 M
About MapLight Therapeutics, Inc.
Sector
Industry
CEO
Christopher A. Kroeger
Website
Headquarters
Redwood City
Founded
2018
ISIN
US56565P1030
FIGI
BBG01JZ5DBQ0
MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for brain disorders. It develops the ML-007-MA product for treatment of schizophrenia and ADP. Its platforms include Optogenetics, Transcriptnomics, and STARmap. The company was founded by Christopher A. Kroeger, Karl Deisseroth, Robert Malenka, and Karoly Nikolich in November 2018 and is headquartered in Redwood City, CA.
Related stocks
Frequently Asked Questions
The current price of MPLT is 15.78 USD — it has decreased by −3.96% in the past 24 hours. Watch MapLight Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange MapLight Therapeutics, Inc. stocks are traded under the ticker MPLT.
MPLT stock has fallen by −8.51% compared to the previous week, the month change is a −14.53% fall, over the last year MapLight Therapeutics, Inc. has showed a −16.95% decrease.
MPLT reached its all-time high on Oct 27, 2025 with the price of 20.86 USD, and its all-time low was 15.00 USD and was reached on Oct 29, 2025. View more price dynamics on MPLT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track MapLight Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
MPLT net income for the last quarter is −29.85 M USD, while the quarter before that showed −22.34 M USD of net income which accounts for −33.60% change. Track more MapLight Therapeutics, Inc. financial stats to get the full picture.
No, MPLT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MPLT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MapLight Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.